Roivant Sciences Ltd. Annual Reports (10-K)
Every annual report 10-K going back 19 years. Put here in one place for you.
Page 1 of 19
2026-2020
| Currency in USD | 2026 |
|---|---|
| Operating Income | -365.99 Million |
| Income Before Tax | -294.56 Million |
| Income Tax Expense | -3.96 Million |
| Net Income | -189.84 Million |
| Eps | -0.26 |
| Epsdiluted | -0.26 |
| Weighted Average Shs Out | 720.78 Million |
| Weighted Average Shs Out Dil | 720.78 Million |
| Research And Development Expenses | 202.02 Million |
| Selling General And Administrative Expenses | N/A |
| Depreciation And Amortization | 600.00 Thousand |
| Interest Expense | N/A |
| Interest Income | 36.92 Million |
| Net Interest Income | 36.92 Million |
| Premiums Earned | N/A |
| Policyholder Benefits | N/A |
| Gross Profit | 1.16 Million |
| Ebitda | -365.39 Million |
| Source | edgar |
| Ebit | -366.38 Million |